ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trade Desk
TTD
|
+$145M |
| 2 |
Recursion Pharmaceuticals
RXRX
|
+$98.2M |
| 3 |
ProShares Bitcoin Strategy ETF
BITO
|
+$82.3M |
| 4 |
CRISPR Therapeutics
CRSP
|
+$75.9M |
| 5 |
XYZ
Block Inc
XYZ
|
+$56.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coinbase
COIN
|
+$219M |
| 2 |
DraftKings
DKNG
|
+$77.3M |
| 3 |
Roku
ROKU
|
+$76.2M |
| 4 |
UiPath
PATH
|
+$75.3M |
| 5 |
Tesla
TSLA
|
+$65.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.49% |
| 2 | Healthcare | 27.9% |
| 3 | Financials | 11.83% |
| 4 | Communication Services | 11.57% |
| 5 | Consumer Discretionary | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Coinbase
COIN
$42.6B
| $1.5B | 8.85% |
8,599,683
-2,003,881
| -19% | -$219M |
|
|
2
UiPath
PATH
$6.06B
| $1.08B | 6.39% |
43,470,597
-3,855,679
| -8% | -$75.3M |
|
|
3
Tesla
TSLA
$1.2T
| $945M | 5.59% |
3,802,519
-276,132
| -7% | -$65.6M |
|
|
XYZ
4
Block Inc
XYZ
$48.6B
| $920M | 5.44% |
11,887,628
+1,000,514
| +9% | +$56.6M |
|
|
5
Roku
ROKU
$21.3B
| $873M | 5.17% |
9,528,872
-910,941
| -9% | -$76.2M |
|
6
Zoom
ZM
$26.7B
| $788M | 4.67% |
10,964,576
+781,663
| +8% | +$51.7M |
|
7
Roblox
RBLX
$34.8B
| $544M | 3.22% |
11,906,173
-67,708
| -0.6% | -$2.5M |
|
8
Twilio
TWLO
$29.2B
| $541M | 3.2% |
7,130,187
-1,825
| -0% | -$114K |
|
|
9
CRISPR Therapeutics
CRSP
$4.61B
| $534M | 3.16% |
8,536,104
+1,372,986
| +19% | +$75.9M |
|
10
Unity
U
$13.3B
| $498M | 2.95% |
12,189,778
+712,579
| +6% | +$22M |
|
11
Shopify
SHOP
$169B
| $468M | 2.77% |
6,010,496
-944,654
| -14% | -$60.3M |
|
12
Teladoc Health
TDOC
$1.61B
| $457M | 2.71% |
21,224,565
+912,692
| +4% | +$16.8M |
|
|
EXAS
13
DELISTED
Exact Sciences
EXAS
| $446M | 2.64% |
6,032,893
-248,038
| -4% | -$16.3M |
|
14
Robinhood
HOOD
$81.2B
| $445M | 2.64% |
34,936,204
+2,101,325
| +6% | +$20.9M |
|
|
15
DraftKings
DKNG
$12.1B
| $434M | 2.57% |
12,317,235
-2,310,617
| -16% | -$77.3M |
|
16
Intellia Therapeutics
NTLA
$1.48B
| $348M | 2.06% |
11,412,449
+1,463,820
| +15% | +$42.1M |
|
17
Pacific Biosciences
PACB
$422M
| $338M | 2% |
34,504,273
+4,681,833
| +16% | +$38.3M |
|
18
Ginkgo Bioworks
DNA
$487M
| $336M | 1.99% |
4,965,165
+410,360
| +9% | +$25.1M |
|
19
Twist Bioscience
TWST
$5.3B
| $266M | 1.57% |
7,213,257
+427,274
| +6% | +$9.88M |
|
20
PagerDuty
PD
$772M
| $264M | 1.56% |
11,413,423
+858,838
| +8% | +$18.6M |
|
21
Beam Therapeutics
BEAM
$2.58B
| $256M | 1.51% |
9,393,889
+609,998
| +7% | +$15.2M |
|
22
10x Genomics
TXG
$5.8B
| $226M | 1.34% |
4,041,287
+1,047,827
| +35% | +$45.6M |
|
23
Veracyte
VCYT
$4.46B
| $211M | 1.25% |
7,655,603
+62,011
| +0.8% | +$1.5M |
|
|
24
Recursion Pharmaceuticals
RXRX
$1.56B
| $204M | 1.21% |
20,654,287
+13,777,689
| +200% | +$98.2M |
|
25
Palantir
PLTR
$297B
| $188M | 1.11% |
10,937,859
+1,514,232
| +16% | +$27M |
|
Similar funds
ARK Investment Management's Q4 2023 Portfolio in Review
As of Q4 2023, ARK Investment Management held 228 positions worth $16.9B, up 29% from $13.1B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.1%. ARK Investment Management opened 2 new positions and exited 5, leaving the 228-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- ARK Investment Management's largest Q4 2023 buy was ProShares Bitcoin Strategy ETF: 4,549,207 shares worth $93.2M.
- ARK Investment Management added most to Trade Desk in Q4 2023, an estimated $145M increase.
- ARK Investment Management's biggest Q4 2023 reduction was Coinbase, cutting an estimated $219M.
- ARK Investment Management fully exited General Motors in Q4 2023, selling an estimated $9.66M.
- ARK Investment Management's ten largest holdings make up 49% of its $16.9B portfolio in Q4 2023.
- ARK Investment Management opened 2 new positions and closed 5 in Q4 2023.
- ARK Investment Management's portfolio value rose 29% quarter-over-quarter to $16.9B.
Based on ARK Investment Management's 13F filing for Q4 2023, filed 17 Jan 2024.